Results for all evidence | Prescribing and Technical Information | Scottish Medicines Consortium - SMC 41 - 50 of 1716 sorted by relevance / date

Indication: for the prevention and treatment of hyperuricaemia in adult patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of Tumour Lysis Syndrome (TLS).

Indication: Hypercholesterolaemia and Homozygous Familial Hypercholesterolaemia

Indication: Treatment of breakthrough pain (BTP) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Indication: Management of acute moderate to severe post-operative pain in adult patients

Indication: For the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs...

Indication: Breakthrough pain in adults with cancer

Indication: Management of breakthrough pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain

Indication: treatment of vulvovaginal candidiasis.

Indication: Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain

Indication: Treatment of iron deficiency when oral preparations are ineffective or cannot be used